{"url_path":"/sec/essi/10-k/2026/item-5","section_key":"item-5","section_title":"Item 5 MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1490873/0001477932-26-003725-index.html","accession_number":"0001477932-26-003725","cik":"0001490873","ticker":"ESSI","issuer_name":"ECO SCIENCE SOLUTIONS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1490873/0001477932-26-003725-index.html","primary_entity_key":"0001490873","primary_entity_name":"ECO SCIENCE SOLUTIONS, INC."},"word_count":581,"has_tables":true,"body_markdown":"**ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**\n\n \n\n**Market Information**\n\n \n\nThe Company’s common stock is quoted on the OTCID Market operated by OTC Markets Group Inc. under the trading symbol “ESSI.”\n\n \n\nThe Company’s securities were initially quoted on the OTC Markets in September 2010 under the name “Pristine Solutions, Inc.” The Company subsequently changed its name to “Eaton Scientific Systems, Inc.” and later to “Eco Science Solutions, Inc.” During May 2017, trading in the Company’s securities was suspended. On October 6, 2022, the registration of the Company’s securities was revoked by the Securities and Exchange Commission. On December 6, 2024, quotation of the Company’s common stock resumed on the OTC Markets under the trading symbol “ESSI.” On February 7, 2025, FINRA completed processing of the Company’s Form 211, permitting broker-dealers to resume publication of quotations for the Company’s common stock.\n\n \n\nOn May 4, 2026, the Company effected a 1-for-25 reverse stock split of its issued and outstanding common stock. Unless otherwise indicated, all share and per share amounts presented in this Annual Report on Form 10-K have been retroactively adjusted to reflect the reverse stock split.\n\n \n\n**Holders**\n\n \n\nAs of the date of this Annual Report on Form 10-K, there were approximately 88 holders of record of the Company’s common stock.\n\n \n\n**Dividends**\n\n \n\nThe Company has not declared or paid any cash dividends on its common stock during the fiscal years ended January 31, 2026 and 2025. The Company currently intends to retain any future earnings, if any, to fund the development and growth of its business and does not presently anticipate paying cash dividends in the foreseeable future.\n\n \n\n**Recent Sales of Unregistered Securities**\n\n \n\nOn January 31, 2026, the Company issued an aggregate of 22,834,297 shares of restricted common stock in connection with the settlement and conversion of accrued compensation, accounts payable, notes payable, convertible notes, and accrued interest totaling approximately $15,984,008. The shares were issued at an adjusted stated issuance price of $0.70 per share after giving effect to the May 4, 2026 reverse stock split.\n\n \n\nFor financial reporting purposes, the shares issued in connection with the debt settlement transactions were recorded at their estimated aggregate fair value of approximately $6.1 million based on the estimated fair value of the common stock on the date of issuance. As a result, the Company recognized gains on debt settlement and extinguishment representing the excess of the carrying value of the liabilities extinguished over the estimated fair value of the equity instruments issued.\n\n \n\nThe issuances were completed in reliance upon exemptions from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D promulgated thereunder. The recipients represented their intention to acquire the securities for investment only and not with a view toward distribution. Appropriate restrictive legends were affixed to the certificates or book-entry statements representing the securities.\n\n \n\nThe Company did not issue any securities during the fiscal year ended January 31, 2025.\n\n \n\n**Issuer Purchases of Equity Securities**\n\n \n\nThe Company did not repurchase any of its equity securities during the fiscal year ended January 31, 2026.\n\n \n\nAs of January 31, 2026, the Company had 24,992,656 shares of common stock issued, of which 40,000 shares were held as treasury stock, resulting in 24,952,656 shares of common stock outstanding.\n\n \n\nAs of January 31, 2025, the Company had approximately 2,158,359 shares of common stock issued, of which 40,000 shares were held as treasury stock, resulting in approximately 2,118,359 shares of common stock outstanding."}